Leeds 3rd Highest Recruiter in world for MelMart Study

Tuesday 16th January 2018

The Leeds Teaching Hospitals Trust (LTHT), with the support of the Leeds Clinical Research Facility (LCRF), is the third highest recruiter world-wide for the MelMart study. This study (Melanoma Margins Trial) looked at whether smaller surgical excisions would be enough to reduce the risk of melanoma returning. The MelMart study is a pilot study; the goal is to determine whether patients can be recruited and if the study procedures could logistically be done. We would like to thank Mr Howard Peach, the principal investigator, Johanne Sugden, the lead research nurse, and the rest of the melanoma team for their hard work in delivering this study.

Full title of study: A Phase III, multicentre, multinational randomised control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma- Pilot Study
Research Ethics Committee (REC) Number: 14/EE/1254